|
|||||
|
|
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC) |
|
| Authors: | Daniel J. Allendorf Rodolfo E. Bordoni Stefan C. Grant Mansoor N. Saleh Vishnu B. Reddy Mary L. Jerome Pamela M. Dixon Deborah K. Miley Karan P. Singh Francisco Robert |
| Affiliation: | 1. Alabama Oncology, Shelby County, AL, USA 2. Georgia Cancer Specialists/Northside Hospital Cancer Institute, Atlanta, GA, USA 3. Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA 4. Division of Hematology/Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, 1824 6th Avenue South, WTI 210B, Birmingham, AL, 35294-3300, USA 5. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA 6. Clinical Studies Unit, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA 7. Clinical Trials Network Office, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA 8. Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |